Addressing the Opioid Crisis in 2020
The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.
An Update on Pharmacists’ Vaccination Authority
Progress has been made, but there’s still a long road ahead.
Eli Lilly Introduces New Lower-Priced Versions of Humalog Insulin Products
Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.
Effect of Long-Term Antipsychotic Use on Morbidity, Mortality Risk
Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study.
A Look Ahead: What to Expect from the Pharmacy Landscape in 2020
Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.
Educating Patients on the Latest Diabetes Technology
Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.
Study: Nasal Spray Naloxone Easiest to Use for Untrained Individuals
A study evaluated the ability of untrained individuals to use different forms of naloxone administration.
Most Valuable Drugs in the 2020 Pipeline
Here are the top drugs expected to be approved this year.
Pharmacists Top Most Trusted Professions in Gallup Poll
NACDS says DIR fees, other policies need to change.
Investigational Immunotherapy for Peanut Allergy Shows Long-Term Clinical Benefit
Viaskin Peanut (DBV Technologies) achieved durable, long-term clinical benefit in peanut-allergic children.
Cardiovascular Disease Linked to Increased Risk of Kidney Failure
Individuals with a history of heart disease may be at an increased risk of developing kidney failure.
WHO Insulin Prequalification Program to Expand Access
Pharmacy Chains Counter Allegations in Federal Opioid Lawsuit
In a new lawsuit, CVS, Walgreen, Rite Aid, and other major pharmacy chains said that they are not to blame in federal opioid litigation
Cancer Mortality Continues Decline, Progress Driven by New Treatments
Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.
Prediabetes On the Rise Among US Teens and Young Adults
Prediabetes can increase the risk the risk of developing type 2 diabetes.
Intensive or Standard Blood Pressure Control for Patients Aged 80 and Older
Are the benefits of lowering systolic blood pressure to less than 130 mm Hg the same for those aged 80 years and older as they are for younger patients?
The Impact of Patents and Exclusivities on FDA’s Approval of Generic Drugs
What are some of the factors affecting whether a brand-name drug has generic competition?
Dapagliflozin Granted Priority Review for Heart Failure with Reduced Ejection Fraction
AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.
FDA OKs Fast-Acting Insulin Aspart Injection for Children with Diabetes
Insulin aspart injection (Fiasp, Novo Nordisk) has been approved for use as a new mealtime insulin option for children with diabetes.
Relying on Your Distributor Through Natural Disasters
The critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain
FDA Issues Complete Response Letter to Investigational Long-Acting HIV Regimen
The New Drug Application is seeking approval for ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV in adults.
Novo Nordisk Announces New Insulin Affordability Options
Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.
Diabetes an Independent Risk Factor for Heart Failure
A new study examined diabetes as an independent predictor of heart failure.
Policy Eliminating Non-Medical Vaccine Exemptions Linked to Improved Coverage Rates
A 2016 California policy that eliminated non-medical vaccination exemptions for schoolchildren was linked to an increase in vaccine coverage.
Survey: Pharmacies Can Improve Medication Disposal Education Efforts
Pharmacies can play an important role in raising awareness about efficient medication disposal methods.
FDA Approves Maintenance Olaparib for Metastatic Pancreatic Cancer
Olaparib (Lynparza, Merck and AstraZeneca) is approved for the maintenance treatment of adult patients with germline BRCA-mutated metastatic pancreatic cancer.
Recommended Vaccines for Patients with Diabetes
Patients with diabetes are at risk for complications from vaccine-preventable diseases, making immunization especially critical.
Looking Back at 2019, and Planning Ahead
In 2020, we know there will be a renewed focus on collaborating across health care specialties while reducing costs.
FDA Approves Generic Versions of Apixaban
The approvals were granted to generic apixaban applications from Micro Labs Limited and Mylan Pharmaceuticals Inc.
Top FDA Drug Approvals from 2019
Our most-read FDA approval articles from 2019.
